Jean-Pierre Savineau Selected Research

1,6-bis(cyclohexyloximinocarbonyl)hexane

4/2007

Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre Savineau Research Topics

Disease

19	Pulmonary Hypertension 01/2020 - 08/2003
13	Hypoxia (Hypoxemia) 01/2020 - 11/2003
5	Pulmonary Arterial Hypertension 01/2017 - 06/2004
4	Hypertension (High Blood Pressure) 03/2013 - 08/2003
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 09/2014
2	Vascular Diseases (Vascular Disease) 01/2017 - 04/2008
2	Atherosclerosis 01/2017 - 03/2013
2	Inflammation (Inflammations) 01/2016 - 06/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2015 - 02/2012
2	Right Ventricular Hypertrophy 08/2013 - 01/2013
2	Hypersensitivity (Allergy) 03/2011 - 03/2002
1	Familial Primary Pulmonary Hypertension 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Asthma (Bronchial Asthma) 01/2016
1	Acute Lung Injury 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Arteritis 08/2015
1	Pain (Aches) 08/2015
1	Heart Failure 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2013
1	Right Ventricular Dysfunction 12/2012
1	Vascular Remodeling 05/2010
1	Body Weight (Weight, Body) 10/2007
1	Weight Gain 10/2007
1	Hypertrophy 08/2003

Drug/Important Bio-Agent (IBA)

6	Dehydroepiandrosterone (DHEA)IBA 08/2013 - 08/2003
5	CalciumIBA 01/2017 - 03/2002
3	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 06/2004
3	MonocrotalineIBA 01/2017 - 03/2011
2	Vasoconstrictor AgentsIBA 01/2017 - 06/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013 - 07/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2013 - 07/2006
2	Ion Channels (Ion Channel)IBA 04/2008 - 01/2007
1	Oxygen (Dioxygen)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Connexin 43 (Connexin43)IBA 01/2020
1	HMGB1 Protein (HMG1)IBA 11/2017
1	terameprocolIBA 11/2017
1	ConnexinsIBA 01/2016
1	Actins (F Actin)IBA 01/2016
1	TubulinIBA 01/2016
1	CytokinesIBA 08/2015
1	Blocking AntibodiesIBA 08/2015
1	Nerve Growth Factor (NGF)IBA 08/2015
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 09/2014
1	2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA 09/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014
1	AntioxidantsIBA 06/2013
1	SteroidsIBA 03/2013
1	7,8-dihydrobiopterinIBA 01/2013
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 01/2013
1	sepiapterinIBA 01/2013
1	Guanosine Triphosphate (GTP)IBA 01/2013
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2013
1	EnzymesIBA 01/2013
1	BiopterinsIBA 01/2013
1	PotassiumIBA 03/2011
1	Vasodilator Agents (Vasodilators)IBA 05/2010
1	Pharmaceutical PreparationsIBA 05/2010
1	Ethanol (Ethyl Alcohol)IBA 10/2007
1	GadoliniumIBA 04/2007
1	NitrendipineIBA 04/2007
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 04/2007
1	Calcium Channels (Calcium Channel)IBA 04/2007
1	1,6-bis(cyclohexyloximinocarbonyl)hexaneIBA 04/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2006
1	NucleotidesIBA 09/2004
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2004
1	Sildenafil Citrate (Viagra)FDA Link 09/2004
1	iberiotoxinIBA 11/2003
1	4-Aminopyridine (4 Aminopyridine)FDA Link 03/2002

Therapy/Procedure

1	Therapeutics 05/2010
1	Oral Administration 08/2003